Across TCGA pan-cancer cohorts, RNU105C RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated RNU105C data layer.
The strongest signal is observed in uterine carcinosarcoma (UCS), where higher RNU105C RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU105C expression acts as an unfavorable survival marker.
UCS, LIHC, and ACC are the cancer types where RNU105C RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.